← Leaderboards
Michael E. Berens
St. Joseph'S Hospital And Medical Center
$13,517,707
Attributed
$16,747,077
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,747,077 · 12
By mechanism
R01$5,081,785 · 3
U01$4,058,531 · 1
RC2$2,700,503 · 1
P01$2,469,220 · 1
U19$1,622,548 · 4
R21$412,776 · 1
Top collaborators
- Gary L. Johnson4 shared
- Christopher Ryan Miller4 shared
- Christopher Hulme1 shared
- Laurence H Hurley1 shared
- Nathalie Meurice1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGlioblastomaGliomaGenesResponsePre-Clinical ModelTumorTranscriptome SequencingIn VivoXenograft ProcedureMolecularBaseResourcesPhenotypeResearch PersonnelGenomicsSpecimenEngineeringGrowthTechnologyMolecular ProfilingPatient Derived Xenograft ModelBioinformaticsPathway Interactions
Grant awards (36)
Molecular Profiling and Bioinformatics$243,372
U19 · FY2025 · CA · contact PI
Core C: Experimental Models$531,423
P01 · FY2024 · CA · contact PI
Molecular Profiling and Bioinformatics$215,705
U19 · FY2024 · CA · contact PI
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat$94,802
U19 · FY2024 · CA · contact PI
Core C: Experimental Models$548,201
P01 · FY2023 · CA · contact PI
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat$196,205
U19 · FY2023 · CA · contact PI
Molecular Profiling and Bioinformatics$175,243
U19 · FY2023 · CA · contact PI
Core C: Experimental Models$548,945
P01 · FY2022 · CA · contact PI
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat$200,563
U19 · FY2022 · CA · contact PI
Molecular Profiling and Bioinformatics$131,059
U19 · FY2022 · CA · contact PI
Core C: Experimental Models$251,139
P01 · FY2021 · CA · contact PI
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat$234,722
U19 · FY2021 · CA · contact PI
Molecular Profiling and Bioinformatics$130,877
U19 · FY2021 · CA · contact PI
Core C: Experimental Models$589,512
P01 · FY2020 · CA · contact PI
Credentialing murine models for glioblastoma preclinical drug development$472,269
R01 · FY2019 · CA
Glioblastoma multiforme therapy via telomerase reverse transcriptase (hTERT) down-regulation. Molecular chaperones redirect quadruplex folding to reverse the effect of hTERT gene promoter mutations.$401,714
R41 · FY2019 · NS
Credentialing murine models for glioblastoma preclinical drug development$133,154
R01 · FY2019 · CA
Credentialing murine models for glioblastoma preclinical drug development$605,422
R01 · FY2018 · CA
Credentialing murine models for glioblastoma preclinical drug development$631,422
R01 · FY2017 · CA
Systematic Development of Novel, Druggable Cancer Targets$794,238
U01 · FY2016 · CA · contact PI
Systematic Development of Novel, Druggable Cancer Targets$805,604
U01 · FY2015 · CA · contact PI
Systematic Development of Novel, Druggable Cancer Targets$788,540
U01 · FY2014 · CA · contact PI
Systematic Development of Novel, Druggable Cancer Targets$783,005
U01 · FY2013 · CA · contact PI
Systematic Development of Novel, Druggable Cancer Targets$887,144
U01 · FY2012 · CA · contact PI
The Southwest Comprehensive Center for Drug Discovery and Development$2,700,503
RC2 · FY2010 · MH
Genetics Pathways of Glioma Invasion$405,644
R01 · FY2008 · NS · contact PI
Genetics Pathways of Glioma Invasion$405,644
R01 · FY2007 · NS · contact PI
Genetics Pathways of Glioma Invasion$417,760
R01 · FY2006 · NS · contact PI
Genetics Pathways of Glioma Invasion$427,813
R01 · FY2005 · NS
Arrested migration fosters apoptosis of glioma cells$219,688
R21 · FY2004 · NS
Genetic Pathways of Glioma Invasion$499,899
R01 · FY2003 · NS
Arrested migration fosters apoptosis of glioma cells$193,088
R21 · FY2003 · NS
Genetic Pathways of Glioma Invasion$447,664
R01 · FY2002 · NS
Genetic Pathways of Glioma Invasion$44,634
R01 · FY2002 · NS
Genetic Pathways of Glioma Invasion$366,318
R01 · FY2001 · NS
ALLOGENIC GLIOMA IN IMMUNE COMPETENT DOGS$224,142
R01 · FY2000 · NS